DE69016826D1 - Verfahren zur Synthese von Ribonukleinsäure (RNS). - Google Patents

Verfahren zur Synthese von Ribonukleinsäure (RNS).

Info

Publication number
DE69016826D1
DE69016826D1 DE69016826T DE69016826T DE69016826D1 DE 69016826 D1 DE69016826 D1 DE 69016826D1 DE 69016826 T DE69016826 T DE 69016826T DE 69016826 T DE69016826 T DE 69016826T DE 69016826 D1 DE69016826 D1 DE 69016826D1
Authority
DE
Germany
Prior art keywords
synthesis
ribonucleic acid
rna
target sequence
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69016826T
Other languages
English (en)
Other versions
DE69016826T2 (de
Inventor
Lawrence T Malek
Cheryl Davey
Peter Franklin Lens
Frits Wielaard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Application granted granted Critical
Publication of DE69016826D1 publication Critical patent/DE69016826D1/de
Publication of DE69016826T2 publication Critical patent/DE69016826T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69016826T 1989-05-10 1990-05-08 Verfahren zur Synthese von Ribonukleinsäure (RNS). Expired - Lifetime DE69016826T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8901172 1989-05-10

Publications (2)

Publication Number Publication Date
DE69016826D1 true DE69016826D1 (de) 1995-03-23
DE69016826T2 DE69016826T2 (de) 1995-06-08

Family

ID=19854626

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69016826T Expired - Lifetime DE69016826T2 (de) 1989-05-10 1990-05-08 Verfahren zur Synthese von Ribonukleinsäure (RNS).

Country Status (13)

Country Link
US (1) US5466586A (de)
EP (1) EP0397269B1 (de)
JP (1) JP2839639B2 (de)
KR (1) KR0185376B1 (de)
AT (1) ATE118549T1 (de)
AU (1) AU641159B2 (de)
CA (1) CA2016358C (de)
DE (1) DE69016826T2 (de)
DK (1) DK0397269T3 (de)
ES (1) ES2070995T3 (de)
FI (1) FI102387B1 (de)
IE (1) IE66597B1 (de)
ZA (1) ZA903453B (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622820A (en) * 1988-03-10 1997-04-22 City Of Hope Method for amplification and detection of RNA and DNA sequences
GB8808892D0 (en) * 1988-04-15 1988-05-18 British Bio Technology Gene synthesis
US5130238A (en) * 1988-06-24 1992-07-14 Cangene Corporation Enhanced nucleic acid amplification process
US5169766A (en) * 1991-06-14 1992-12-08 Life Technologies, Inc. Amplification of nucleic acid molecules
EP0675965A4 (de) * 1992-01-29 1999-01-20 Hitachi Chemical Co Ltd Träger zur immobilisierung von polynukleotiden.
KR100249110B1 (ko) * 1992-05-06 2000-04-01 다니엘 엘. 캐시앙 핵산 서열 증폭 방법, 이에 이용되는 조성물 및 키트
EP0652971A4 (de) * 1992-07-28 1998-12-02 Hitachi Chemical Co Ltd Detektionssystem für gene.
US5712127A (en) * 1996-04-29 1998-01-27 Genescape Inc. Subtractive amplification
DE19633427C2 (de) * 1996-08-20 2001-10-04 Hubert S Bernauer Verfahren zur Synthese von Nukleinsäuremolekülen mit zumindest teilweise vorbestimmter Nukleotidsequenz
DE19812103A1 (de) * 1998-03-19 1999-09-23 Bernauer Annette Verfahren zur Synthese von Nucleinsäuremolekülen
JP2004528028A (ja) * 2001-03-07 2004-09-16 バイオメリオ・ベー・ベー 転写による増幅を使用したｄｎａの増幅及び検出法
CN1269966C (zh) 2001-03-07 2006-08-16 拜奥默里克斯有限公司 用基于转录的扩增来扩增和检测hbvdna的方法
AU2003303395A1 (en) * 2001-05-22 2004-07-22 Dahl, Gary, A. Target-dependent transcription using deletion mutants of n4 rna polymerase
US8137911B2 (en) * 2001-05-22 2012-03-20 Cellscript, Inc. Preparation and use of single-stranded transcription substrates for synthesis of transcription products corresponding to target sequences
US7504215B2 (en) 2002-07-12 2009-03-17 Affymetrix, Inc. Nucleic acid labeling methods
US20050003369A1 (en) * 2002-10-10 2005-01-06 Affymetrix, Inc. Method for depleting specific nucleic acids from a mixture
EP1585824A4 (de) 2002-11-21 2008-01-02 Epict Technologies Herstellung und verwendung einzelsträngiger transkriptionssubstrate zur synthese von zielsequenzen entsprechenden transkriptionsprodukten
US7266295B2 (en) * 2003-04-17 2007-09-04 Intel Corporation Modular reconfigurable multi-server system and method for high-speed networking within photonic burst-switched network
CA2898814C (en) * 2004-08-27 2015-12-29 Gen-Probe Incorporated Single-primer nucleic acid amplification methods
US7713697B2 (en) * 2004-08-27 2010-05-11 Gen-Probe Incorporated Methods and kits for amplifying DNA
EP1882036B1 (de) 2005-05-17 2012-02-15 Ozgene Pty Ltd Sequentielles klonierungssystem
US8293684B2 (en) * 2006-11-29 2012-10-23 Exiqon Locked nucleic acid reagents for labelling nucleic acids
US8183359B2 (en) * 2007-03-01 2012-05-22 Gen-Probe Incorporated Kits for amplifying DNA
EP2173872B1 (de) * 2007-06-29 2014-04-02 CellScript, Inc. Copy-dna und sense-rna
WO2010126913A1 (en) 2009-04-27 2010-11-04 Gen-Probe Incorporated Methods and kits for use in the selective amplification of target sequences
WO2010148085A1 (en) 2009-06-16 2010-12-23 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Rna nanoparticles and methods of use
TWI518325B (zh) 2010-02-04 2016-01-21 自治醫科大學 對ａｌｋ抑制劑具有先抗性或後抗性癌症的識別、判斷和治療
CA2807552A1 (en) 2010-08-06 2012-02-09 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
CN104531812A (zh) 2010-10-01 2015-04-22 现代治疗公司 设计核酸及其使用方法
WO2012135805A2 (en) 2011-03-31 2012-10-04 modeRNA Therapeutics Delivery and formulation of engineered nucleic acids
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
RU2707251C2 (ru) 2011-10-03 2019-11-25 Модерна Терапьютикс, Инк. Модифицированные нуклеозиды, нуклеотиды и нуклеиновые кислоты и их применение
KR20140102759A (ko) 2011-12-16 2014-08-22 모더나 세라퓨틱스, 인코포레이티드 변형된 뉴클레오사이드, 뉴클레오타이드 및 핵산 조성물
FR2984357B1 (fr) 2011-12-16 2016-11-18 Biomerieux Sa Procede d'amplification transcriptionnelle d'acides nucleiques reunissant des etapes de temperatures differentes
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US9878056B2 (en) 2012-04-02 2018-01-30 Modernatx, Inc. Modified polynucleotides for the production of cosmetic proteins and peptides
EP2833892A4 (de) 2012-04-02 2016-07-20 Moderna Therapeutics Inc Modifizierte polynukleotide zur herstellung von in der onkologie nützlichen proteinen und peptiden
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
JP6144355B2 (ja) 2012-11-26 2017-06-07 モデルナティエックス インコーポレイテッドＭｏｄｅｒｎａＴＸ，Ｉｎｃ． 化学修飾ｍＲＮＡ
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
WO2015006344A1 (en) * 2013-07-08 2015-01-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Method for synthesizing selectively labeled rna
SG10201806890VA (en) 2013-08-28 2018-09-27 Cellular Res Inc Massively parallel single cell analysis
AU2014321443B2 (en) 2013-09-17 2020-07-09 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Multifunctional RNA nanoparticles and methods of use
WO2015048744A2 (en) 2013-09-30 2015-04-02 Moderna Therapeutics, Inc. Polynucleotides encoding immune modulating polypeptides
US10323076B2 (en) 2013-10-03 2019-06-18 Modernatx, Inc. Polynucleotides encoding low density lipoprotein receptor
US20160274095A1 (en) 2013-11-13 2016-09-22 Inserm (Institut National De La Sante Et De La Recherche Medicale Kits-of-Parts Comprising Nucleic Acids Able to Form a Kissing Complex and Their uses Thereof
WO2015171827A1 (en) 2014-05-06 2015-11-12 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Triggering rna interference with rna-dna and dna-rna nanoparticles
WO2018187373A1 (en) 2017-04-03 2018-10-11 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Functionally-interdependent shape switching nucleic acid nanoparticles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4766072A (en) * 1985-07-17 1988-08-23 Promega Corporation Vectors for in vitro production of RNA copies of either strand of a cloned DNA sequence
IL86724A (en) * 1987-06-19 1995-01-24 Siska Diagnostics Inc Methods and kits for amplification and testing of nucleic acid sequences
DE68908054T2 (de) * 1988-01-21 1994-03-10 Genentech Inc Verstärkung und nachweis von nukleinsäuresequenzen.
CA1340807C (en) * 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process

Also Published As

Publication number Publication date
ATE118549T1 (de) 1995-03-15
DK0397269T3 (da) 1995-05-29
EP0397269A1 (de) 1990-11-14
FI102387B (fi) 1998-11-30
JPH03180184A (ja) 1991-08-06
DE69016826T2 (de) 1995-06-08
US5466586A (en) 1995-11-14
EP0397269B1 (de) 1995-02-15
CA2016358C (en) 2000-11-28
AU641159B2 (en) 1993-09-16
FI902318A0 (fi) 1990-05-09
ES2070995T3 (es) 1995-06-16
KR900018376A (ko) 1990-12-21
JP2839639B2 (ja) 1998-12-16
KR0185376B1 (ko) 1999-04-01
IE66597B1 (en) 1996-01-24
CA2016358A1 (en) 1990-11-10
AU5487790A (en) 1990-11-15
IE901624L (en) 1990-11-10
ZA903453B (en) 1991-02-27
FI102387B1 (fi) 1998-11-30

Similar Documents

Publication Publication Date Title
DE69016826D1 (de) Verfahren zur Synthese von Ribonukleinsäure (RNS).
DE69937223D1 (de) Verfahren zur synthese von nukleinsäuren
DE3850093D1 (de) Verfahren zur Amplifizierung von Nukleinsäuren.
DE69034177D1 (de) Verfahren zur Amplifikation von Nukleinsäuresequenzen
DE69432419D1 (de) Ein elektrochemiluminescenter nachweis von nukleinsäuren auf basis der selbsttragenden sequenzreplikation
ATE365812T1 (de) Verfahren zur unterscheidung von sequenz varianten
DE68916671D1 (de) Mutationsnachweis durch kompetitiven Oligonukleotid-Priming.
DE59008105D1 (de) Modifiziertes Phosphoramidit-Verfahren zur Herstellung von modifizierten Nukleinsäuren.
NO895090D0 (no) Fremgangsmaate og system for deteksjonsdiagnostisering.
BR8907830A (pt) Processo para preparar uma dna de filamento duplo que codifica uma sequencia que corresponde a uma sequencia objetivada de acido nucleico e processo util para deteccao de pelo menos uma sequencia de acido nucleico objetivada especifica
ATE263237T1 (de) Effizientes verfahren zum auffinden von genfunktionen mittels bibliotheken zur funktionellen genomanwendung
DE3687287D1 (de) Verfahren zur amplifikation von nukleinsaeuresequenzen.
CA2264967A1 (en) Method of dna sequencing
DE69626032D1 (de) Modifizierung von oligonukleotid-primer-sequenzen zum manipilieren der zugabe von nicht-template-nukleotiden
SU1759873A1 (ru) Фрагмент дезоксирибонуклиновой кислоты, кодирующий промотор SP6 РНК-полимеразы
DE69622239T2 (de) VERFAHREN ZUR HERSTELLUNG VON cis-3-HYDROXY-L-PROLIN

Legal Events

Date Code Title Description
8364 No opposition during term of opposition